[EN] MODIFIED DOCETAXEL LIPOSOME FORMULATIONS<br/>[FR] FORMULATIONS LIPOSOMALES DE DOCÉTAXEL MODIFIÉ
申请人:MALLINCKRODT LLC
公开号:WO2014160392A1
公开(公告)日:2014-10-02
The present invention provides compositions for the treatment of cancer. The compositions include liposomes containing a phosphatidylcholine lipid, a sterol, a PEG-lipid, and a taxane. The PEG-lipid constitutes from about 2 to about 8 mol % of the lipids in the liposome. The taxane is docetaxel esterified at the 2'-O position with a heterocyclyl-(C2-5alkanoic acid). Methods for preparation of liposomal taxanes and treatment of cancer with liposomal taxanes are also disclosed.